Gossamer Bio (GOSS) Total Current Liabilities (2022 - 2025)
Historic Total Current Liabilities for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to $62.1 million.
- Gossamer Bio's Total Current Liabilities rose 2159.54% to $62.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.1 million, marking a year-over-year increase of 2159.54%. This contributed to the annual value of $45.0 million for FY2024, which is 1276.79% down from last year.
- Per Gossamer Bio's latest filing, its Total Current Liabilities stood at $62.1 million for Q3 2025, which was up 2159.54% from $53.6 million recorded in Q2 2025.
- Over the past 5 years, Gossamer Bio's Total Current Liabilities peaked at $62.1 million during Q3 2025, and registered a low of $34.6 million during Q1 2022.
- In the last 4 years, Gossamer Bio's Total Current Liabilities had a median value of $45.2 million in 2024 and averaged $46.4 million.
- In the last 5 years, Gossamer Bio's Total Current Liabilities tumbled by 1962.01% in 2023 and then soared by 3462.97% in 2025.
- Over the past 4 years, Gossamer Bio's Total Current Liabilities (Quarter) stood at $49.2 million in 2022, then increased by 4.81% to $51.6 million in 2023, then dropped by 12.77% to $45.0 million in 2024, then skyrocketed by 38.01% to $62.1 million in 2025.
- Its last three reported values are $62.1 million in Q3 2025, $53.6 million for Q2 2025, and $48.2 million during Q1 2025.